We are live on ! Find out more
SBIO icon

ALPS Medical Breakthroughs ETF
SBIO

51 hedge funds and large institutions have $55.2M invested in ALPS Medical Breakthroughs ETF in 2019 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 17 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

75,300% more call options, than puts

Call options by funds: $3.77M | Put options by funds: $5K

57% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 7

26% more capital invested

Capital invested by funds: $44M → $55.2M (+$11.2M)

9% more funds holding

Funds holding: 47 → 51 (+4)

2.4% less ownership

Funds ownership: 27.06% → 24.65% (-2.4%)

47% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 17

Holders
51
Holders Change
+4
Holders Change %
+8.51%
% of All Funds
1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
9
Reduced
17
Closed
7
Calls
$3.77M
Puts
$5K
Net Calls
+$3.77M
Net Calls Change
+$1.43M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$437K
2
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
+$428K
3
Wolverine Trading
Wolverine Trading
Illinois
+$257K
4
BRWM
B. Riley Wealth Management
Tennessee
+$255K
5
RA
RFG Advisory
Alabama
+$239K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$953K
2
Bank of America
Bank of America
North Carolina
-$787K
3
Jane Street
Jane Street
New York
-$711K
4
TRCT
Tower Research Capital (TRC)
New York
-$590K
5
RJA
Raymond James & Associates
Florida
-$585K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wolverine Trading
26
Wolverine Trading
Illinois
$292K +$257K +6,923 New
BRWM
27
B. Riley Wealth Management
Tennessee
$291K +$255K +6,880 New
LTFS
28
Ladenburg Thalmann Financial Services
Florida
$284K +$24.2K +652 +11%
RA
29
RFG Advisory
Alabama
$273K +$239K +6,448 New
WS
30
Wedbush Securities
California
$229K +$201K +5,413 New
GIA
31
Gladstone Institutional Advisory
Florida
$216K -$49.3K -1,329 -21%
UCFA
32
United Capital Financial Advisors
Texas
$209K +$184K +4,950 New
AWM
33
AllSquare Wealth Management
New York
$198K +$24.5K +660 +16%
VCP
34
Verus Capital Partners
Arizona
$88K +$77K +2,075 New
APA
35
American Portfolios Advisors
New York
$43.6K +$5.57K +150 +17%
CBT
36
Central Bank & Trust
Kentucky
$42K – – –
GWM
37
Geneos Wealth Management
Colorado
$42K – – –
US Bancorp
38
US Bancorp
Minnesota
$42K +$37.1K +1,000 New
CG
39
Cutler Group
California
$33K +$29.6K +799 New
WEC
40
Winslow Evans & Crocker
Massachusetts
$20K – – –
Bank of Montreal
41
Bank of Montreal
Ontario, Canada
$14K – – –
MPWT
42
MassMutual Private Wealth & Trust
Connecticut
$14K – – –
Simplex Trading
43
Simplex Trading
Illinois
$14K +$12.6K +339 New
GT
44
Glenmede Trust
Pennsylvania
$9K -$3.71K -100 -32%
BWM
45
BerganKDV Wealth Management
Minnesota
$7K – – –
Carson Wealth (CWM LLC)
46
Carson Wealth (CWM LLC)
Nebraska
$5K – – –
SWA
47
Sutton Wealth Advisors
Florida
$4.23K – – –
MWP
48
MYCIO Wealth Partners
Pennsylvania
$4K – – –
NFG
49
Next Financial Group
Texas
$4K – – –
Citigroup
50
Citigroup
New York
$3K +$2.6K +70 New
1
2
3

SBIO Hedge Fund Activity: Q4 2019 in Review

51 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q4 2019, worth a combined $55.2M — up 26% from $44M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new SBIO positions and 7 closed out — a net gain of 4 holders — while 9 added to existing stakes and 17 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $437K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $953K sold.

  • 51 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q4 2019, up from 47 in Q3 2019.
  • Funds reported $55.2M of ALPS Medical Breakthroughs ETF stock for Q4 2019, up 26% quarter-over-quarter.
  • 11 funds opened new ALPS Medical Breakthroughs ETF positions in Q4 2019 and 7 closed out, a net change of +4 holders.
  • The largest ALPS Medical Breakthroughs ETF buyer in Q4 2019 was Morgan Stanley, an estimated $437K added.
  • The largest ALPS Medical Breakthroughs ETF seller in Q4 2019 was Susquehanna International Group, an estimated $953K sold.

Based on aggregated 13F filings for Q4 2019.